{
    "Trade/Device Name(s)": [
        "Glucose Meter-Check Solution for Bayer",
        "Glucose Meter-Check\u00ae Solution for Bayer",
        "Glucose Meter-Check Control Solution"
    ],
    "Submitter Information": "Bionostics, Inc.",
    "510(k) Number": "K123966",
    "Predicate Device Reference 510(k) Number(s)": [
        "K082395"
    ],
    "Regulatory Class": "Class I, reserved",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "January 25, 2013",
    "Summary Letter Received Date": "December 26, 2012",
    "Submission Date": "December 20, 2012",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [],
    "Specimen Container(s)": [
        "Plastic bottle with dropper tip",
        "6 ml white LDPE"
    ],
    "Instrument(s)/Platform(s)": [
        "Bayer Contour Next blood glucose monitoring system",
        "Bayer Breeze 2 blood glucose monitoring system",
        "Bayer Contour blood glucose monitoring system",
        "Bayer Contour TS blood glucose monitoring system"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic measurement"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Glucose Meter-Check Solution, a glucose quality control material for Bayer blood glucose monitoring systems.",
    "Indications for Use Summary": "For in vitro diagnostic use to assess performance of Bayer Contour Next, Breeze 2, Contour, and Contour TS blood glucose monitoring systems by healthcare professionals and individuals with diabetes at home.",
    "fda_folder": "Clinical Chemistry"
}